Ex vivo lung perfusion (EVLP) has become a reality as a technique to evaluate and recondition lungs from marginal donors. We report the first case on the use of EVLP followed by separate transplantation in two different centres. The local organ procurement organization proposed the lungs of a 53-year-old non-smoker donor who died for cerebral haemorrhage. P/F ratio was 294 after lung recruitment manoeuvres. Oto score was 10. Two centres accepted the grafts for two single transplantations under the condition of EVLP evaluation. After usual retrieval, the bi-pulmonary block was transferred to Centre 1 and EVLP was run as previously described. At the end of the procedure the two lungs were evaluated separately and both judged suitable for tran...
BACKGROUND: The method of ex vivo lung perfusion (EVLP) has been suggested as a reliable means of di...
OBJECTIVES: Lung transplantation (LTx) remains the gold standard for patients with end-stage lung di...
Lung transplantation is the only therapeutic option for end-stage pulmonary failure. Nevertheless, t...
Introduction. Ex vivo lung perfusion (EVLP) has become a reality as a technique to evaluate and reco...
OBJECTIVES: Despite progress in lung transplantation (LTx) techniques, a shortage of donor lungs per...
Background Among the strategies to increase the number of lung transplants, ex vivo lung perfusion (...
BACKGROUND: Only about 15% of donor lungs are considered suitable for transplantation (LTx). Ex vivo...
This paper describes the initial clinical experience of ex-vivo lung perfusion (EVLP) at the Fondazi...
ex vivo lung perfusion (EVLP) potentially allows to reduce the donor pool shortage, however its effi...
The number of patients listed for lung transplantation largely exceeds the number of available trans...
Donor lung shortage has been the main reason to the increasing number of patients waiting for lung t...
Lung transplantation is a lifesaving treatment option in well-selected patient with end-stage lung d...
Lung transplantation is a life-saving procedure limited by donor's availability. Lung reconditioning...
Lung transplantation is limited by a scarcity of suitable donors resulting in high waiting list mort...
Background: Many patients awaiting lung transplantation die before a donor organ becomes available. ...
BACKGROUND: The method of ex vivo lung perfusion (EVLP) has been suggested as a reliable means of di...
OBJECTIVES: Lung transplantation (LTx) remains the gold standard for patients with end-stage lung di...
Lung transplantation is the only therapeutic option for end-stage pulmonary failure. Nevertheless, t...
Introduction. Ex vivo lung perfusion (EVLP) has become a reality as a technique to evaluate and reco...
OBJECTIVES: Despite progress in lung transplantation (LTx) techniques, a shortage of donor lungs per...
Background Among the strategies to increase the number of lung transplants, ex vivo lung perfusion (...
BACKGROUND: Only about 15% of donor lungs are considered suitable for transplantation (LTx). Ex vivo...
This paper describes the initial clinical experience of ex-vivo lung perfusion (EVLP) at the Fondazi...
ex vivo lung perfusion (EVLP) potentially allows to reduce the donor pool shortage, however its effi...
The number of patients listed for lung transplantation largely exceeds the number of available trans...
Donor lung shortage has been the main reason to the increasing number of patients waiting for lung t...
Lung transplantation is a lifesaving treatment option in well-selected patient with end-stage lung d...
Lung transplantation is a life-saving procedure limited by donor's availability. Lung reconditioning...
Lung transplantation is limited by a scarcity of suitable donors resulting in high waiting list mort...
Background: Many patients awaiting lung transplantation die before a donor organ becomes available. ...
BACKGROUND: The method of ex vivo lung perfusion (EVLP) has been suggested as a reliable means of di...
OBJECTIVES: Lung transplantation (LTx) remains the gold standard for patients with end-stage lung di...
Lung transplantation is the only therapeutic option for end-stage pulmonary failure. Nevertheless, t...